242 related articles for article (PubMed ID: 33478971)
1. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
Ravindran A; Casal Moura M; Fervenza FC; Nasr SH; Alexander MP; Fidler ME; Herrera Hernandez LP; Zhang P; Grande JP; Cornell LD; Gross LA; Negron V; Jenson GE; Madden BJ; Charlesworth MC; Sethi S
J Am Soc Nephrol; 2021 Mar; 32(3):695-706. PubMed ID: 33478971
[TBL] [Abstract][Full Text] [Related]
2. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.
Wada Y; Iyoda M; Suzuki T; Tachibana S; Kanazawa N; Matsumoto K; Honda H
Virchows Arch; 2021 Nov; 479(5):997-1005. PubMed ID: 34302213
[TBL] [Abstract][Full Text] [Related]
3. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
[TBL] [Abstract][Full Text] [Related]
4. Glomerular Exostosin-Positivity is Associated With Disease Activity and Outcomes in Patients With Membranous Lupus Nephritis.
Xia X; Li S; Wang Z; Ye S; Fan Y; Peng W; Chen W; Huang F; Tang R; Chen W
Kidney Int Rep; 2024 Apr; 9(4):1040-1046. PubMed ID: 38765564
[TBL] [Abstract][Full Text] [Related]
5. EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies.
Miller PP; Caza T; Larsen CP; Charu V
Nephrol Dial Transplant; 2023 Feb; 38(2):396-404. PubMed ID: 35278072
[TBL] [Abstract][Full Text] [Related]
6. Glomerular Exostosin as a Subtype and Activity Marker of Class 5 Lupus Nephritis.
Wang C; Liu Y; Zhang M; Yang F; Xu F; Shi S; Zeng C; Chen X; Miao Y; Liu Z; Hu W
Clin J Am Soc Nephrol; 2022 Jul; 17(7):986-993. PubMed ID: 35584929
[TBL] [Abstract][Full Text] [Related]
7. Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report.
Li L; Yang Z; Tao T; Yang M; Hu ZX
Medicine (Baltimore); 2021 Mar; 100(9):e24887. PubMed ID: 33655949
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
Ye T; Jiang M; Zeng X; Zong D; Du Y; Li X; Huang B; Tang X
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38154829
[TBL] [Abstract][Full Text] [Related]
9. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
[TBL] [Abstract][Full Text] [Related]
10. Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
Liu Z; Wan C; Cao Y; Liu S; Xu Z; Zhang C; Su H
J Nephrol; 2024 Jan; 37(1):149-158. PubMed ID: 37882962
[TBL] [Abstract][Full Text] [Related]
11. A Diagnostic and Therapeutic Dilemma Concerning Exostosin 1/Exostosin 2-associated Lupus-like Membranous Nephropathy with Positive Antinuclear Antibody in an Elderly Man with Various Immune Abnormalities.
Kawagoe M; Odajima K; Asakawa S; Nagura M; Arai S; Yamazaki O; Tamura Y; Ohashi R; Iwakura T; Yasuda H; Shibata S; Fujigaki Y
Intern Med; 2023 Nov; 62(21):3187-3194. PubMed ID: 36948625
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan.
Iwakura T; Ema C; Isobe S; Fujikura T; Ohashi N; Kato A; Yasuda H
Sci Rep; 2022 Feb; 12(1):2967. PubMed ID: 35194125
[TBL] [Abstract][Full Text] [Related]
13. Lupus-like membranous nephropathy: Is it lupus or not?
Sam R; Joshi A; James S; Jen KY; Amani F; Hart P; Schwartz MM
Clin Exp Nephrol; 2015 Jun; 19(3):395-402. PubMed ID: 24993947
[TBL] [Abstract][Full Text] [Related]
14. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
15. A Target Antigen-Based Approach to the Classification of Membranous Nephropathy.
Bobart SA; Tehranian S; Sethi S; Alexander MP; Nasr SH; Moura Marta C; Vrana JA; Said S; Giesen CD; Lieske JC; Fervenza FC; De Vriese AS
Mayo Clin Proc; 2021 Mar; 96(3):577-591. PubMed ID: 33673911
[TBL] [Abstract][Full Text] [Related]
16. Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases.
Iwakura T; Ema C; Sato T; Isobe S; Fujikura T; Ohashi N; Kato A; Yasuda H
Kidney Med; 2021; 3(4):669-673. PubMed ID: 34401734
[TBL] [Abstract][Full Text] [Related]
17. The Clinicopathologic Spectrum of Membranous Nephropathy with Lupus-Like Features.
Choung HYG; Moore C; Le TH; Guirguis P; McKeown JM; Jean-Gilles J; Goldman B
Nephron; 2023; 147(7):424-433. PubMed ID: 36746127
[TBL] [Abstract][Full Text] [Related]
18. Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study.
Zavala-Miranda MF; Sobrino-Vargas AM; Hernández-Andrade A; Caballero-Malacara V; Pérez-Arias AA; Márquez-Macedo SE; Nordmann-Gomes A; Navarro-Sánchez V; Juárez-Cuevas B; Uribe-Uribe NO; Mejia-Vilet JM
Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38922553
[TBL] [Abstract][Full Text] [Related]
19. Tubular expression of Toll-like receptor 9 in lupus and primary membranous nephropathy.
Elloumi N; Fakhfakh R; Masmoudi H; Kammoun K
Tunis Med; 2024 Apr; 102(4):241-244. PubMed ID: 38746965
[TBL] [Abstract][Full Text] [Related]
20. Targeted Next-Generation Sequencing Newly Identifies Mutations in Exostosin-1 and Exostosin-2 Genes of Patients with Multiple Osteochondromas.
Guo X; Lin M; Shi T; Yan W; Chen W
Tohoku J Exp Med; 2017 Jul; 242(3):173-181. PubMed ID: 28690282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
